Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Neuronetics的股價上漲，此前該公司宣佈其NeuroStar高級心理健康療法獲得FDA批准，用於治療焦慮性抑鬱症。
Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Neuronetics的股價上漲，此前該公司宣佈其NeuroStar高級心理健康療法獲得FDA批准，用於治療焦慮性抑鬱症。